Abstract
The gastrointestinal tract communicates directly with the external environment. Necessary nutrients must be absorbed and commensal bacteria tolerated, and foreign proteins, antigens, and pathogens must be simultaneously excluded or destroyed. Immaturity or disruption of the mucosal immune defenses increases vulnerability to food allergy, intolerance, and infectious disease. Diseases resulting from ingested foreign proteins and organisms are increasing and cause morbidity and mortality worldwide. There is no specific treatment for food allergy other than avoidance. Vaccination for infectious disease is limited by the cost and logistics of distribution and administration, particularly in developing countries. Novel strategies are being explored to modulate the gut mucosal immune system by altering protein expression in food. Crops are being developed to remove deleterious allergens to prevent immunogenic exposure while preserving nutritional quality. Local food plants that express protein fragments of pathogens might provide an effective means to stimulate gut mucosal immunity while increasing vaccine accessibility.
Keywords: Celiac Disease, Food Allergy, Allergy Clin Immunol, Protective Antigen, Severe Acute Respiratory Syndrome
References and Recommended Reading
- 1.Mayer L. Mucosal immunity. Pediatrics. 2003;111:1595–1600. [PubMed] [Google Scholar]
- 2.Kagan RS. Food allergy: an overview. Environ Health Perspect. 2003;111:223–225. doi: 10.1289/ehp.5702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Castro GA, Arntzen CJ. Immunophysiology of the gut: a research frontier for integrative studies of the common mucosal immune system. Am J Physiol. 1993;265:G599–G610. doi: 10.1152/ajpgi.1993.265.4.G599. [DOI] [PubMed] [Google Scholar]
- 4.Langridge WHR. Edible vaccines. Sci Am. 2000;283:66–71. doi: 10.1038/scientificamerican0900-66. [DOI] [PubMed] [Google Scholar]
- 5.Sicherer SH, Sampson HA, Burks AW. Peanut and soy allergy: a clinical and therapeutic dilemma. Allergy. 2000;55:515–521. doi: 10.1034/j.1398-9995.2000.00119.x. [DOI] [PubMed] [Google Scholar]
- 6.Bannon GA, Shin D, Maleki S, et al. Tertiary structure and biophysical properties of a major peanut allergen, implications for the production of a hypoallergenic protein. Int Arch Allergy Immunol. 1999;118:315–316. doi: 10.1159/000024115. [DOI] [PubMed] [Google Scholar]
- 7.Rabjohn P, West CM, Connaughton C, et al. Modification of peanut allergen Ara h 3:effects on IgE binding and Tcell stimulation. Int Arch Allergy Immunol. 2002;128:15–23. doi: 10.1159/000057999. [DOI] [PubMed] [Google Scholar]
- 8.Burks AW, Brooks JR, Sampson HA. Allergenicity of major component proteins of soybean determined by enzyme-linked immunosorbent assay (ELISA) and immunoblotting in children with atopic dermatitis and positive soy challenges. J Allergy Clin Immunol. 1988;81:1135–1142. doi: 10.1016/0091-6749(88)90881-0. [DOI] [PubMed] [Google Scholar]
- 9.Ogawa T, Bando N, Tsuji H, et al. Investigation of the IgEbinding proteins in soybeans by immunoblotting with the sera of the soybean-sensitive patients with atopic dermatitis. J Nutr Sci Vitaminol. 1991;37:555–565. doi: 10.3177/jnsv.37.555. [DOI] [PubMed] [Google Scholar]
- 10.Herman EM, Helm RM, Jung R, Kinney AJ. Genetic modification removes an immunodominant allergen from soybean. Plant Physiol. 2003;132:36–43. doi: 10.1104/pp.103.021865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Suszkiw J: Researchers develop first hypoallergenic soybean. ARS National Program (#302) http://www.nps. ars.usda.gov. Accessed September 2002.
- 12.Lemaux PG: Advances in technology for cereal breeding. Biotechnology Symposium. UC Davis. http://ucbiotech/ talks/crops/advances.html. Accessed August 29, 2000.
- 13.Matsumoto T. Mitigation of the action of wheat allergen by acidic oxidative potential water. Allergy. 2002;57:926–930. doi: 10.1034/j.1398-9995.2002.23606.x. [DOI] [PubMed] [Google Scholar]
- 14.Harder B. Target: celiac disease. Therapies aimed to complement or replace the gluten-free diet. Science News. 2003;163:392–393. [Google Scholar]
- 15.Buchanan B: Plant research briefing papers: Dr. Bob Buchanan explains how his research using plant biotechnology is removing allergens from existing foods. October 6, 1999 Statement. American Society of Plant Biologists 2003. http://www.aspb.org/publicaffairs/briefing/ buchanan.cfm. Accessed August 15, 2003.
- 16.Palosuo K. Update on wheat hypersensitivity. Curr Opin Allergy Clin Immunol. 2003;3:205–209. doi: 10.1097/00130832-200306000-00009. [DOI] [PubMed] [Google Scholar]
- 17.Sicherer S. Clinical aspects of gastrointestinal food allergy in childhood. Pediatrics. 2003;111:1609–1616. [PubMed] [Google Scholar]
- 18.Palosuo K, Alenius H, Varjonen E, et al. A novel wheat gliadin as a cause of exercise-induced anaphylaxis. J Allergy Clin Immunol. 1999;103:912–917. doi: 10.1016/S0091-6749(99)70438-0. [DOI] [PubMed] [Google Scholar]
- 19.Williamson D, Marsh MN. Celiac disease. Mol Biotechnol. 2002;22:293–299. doi: 10.1385/MB:22:3:293. [DOI] [PubMed] [Google Scholar]
- 20.Benahmed M, Mention J-J, Matysiak-Budnikk T, et al. Celiac disease: a future without gluten-free diet? Gastroenterology. 2003;125:1264–1267. doi: 10.1016/j.gastro.2003.07.002. [DOI] [PubMed] [Google Scholar]
- 21.MacDonald WC, Brandborg LL, Flick AI, et al. Studies of celiac sprue. IV. The response of the whole length of the small bowel to a gluten-free diet. Gastroenterology. 1964;47:573–589. [PubMed] [Google Scholar]
- 22.Celiac disease. NIH Publication No. 03-4269; http:// digestive.niddkk.nih.gov/ddiseases/pubs/celiac/index.htm. July 2003. Accessed September 12, 2003.
- 23.Iughetti L, Bulgarelli S, Forese S, et al. Endocrine aspects of celiac disease. J Pediatr Endocrinol Metab. 2003;16:805–818. doi: 10.1515/jpem.2003.16.6.805. [DOI] [PubMed] [Google Scholar]
- 24.Battais F, Pineau F, Popineau Y, et al. Food allergy to wheat:identification of immunoglobulin E and immunoglobulin G-binding proteins with sequential extracts and purified proteins from wheat flour. Clin Exp Allergy. 2003;33:962–970. doi: 10.1046/j.1365-2222.2003.01592.x. [DOI] [PubMed] [Google Scholar]
- 25.Vader LW, Stepniak DT, Bunnik EM, et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology. 2003;125:1105–1113. doi: 10.1016/S0016-5085(03)01204-6. [DOI] [PubMed] [Google Scholar]
- 26.Buchanan BB, Adamidi C, Lozano RM, et al. Thioredoxinlinked mitigation of allergic responses to wheat. Proc Natl Acad Sci U S A. 1997;94:5372–5377. doi: 10.1073/pnas.94.10.5372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Barbeau WE, Novascone A, Elgert KD. Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidenti fied superantigen? Mol Immunol. 1997;34:535–541. doi: 10.1016/S0161-5890(97)00068-0. [DOI] [PubMed] [Google Scholar]
- 28.Richter L, Kipp PB. Transgenic plants as edible vaccines. Curr Top Microbiol Immunol. 1999;240:159–176. doi: 10.1007/978-3-642-60234-4_8. [DOI] [PubMed] [Google Scholar]
- 29.James C, Krattiger AF. Global Review of the Field Testing and Commercialization of Transgenic Plants, 1986–1995: The First Decade of Crop Biotechnology. Ithaca, NY: ISAAA Briefs; 1996. pp. 1–1. [Google Scholar]
- 30.May GD, Afza R, Mason HS, et al. Generation of transgenic banana (Musa actiminata) plants via Agrobacteriummediated transformation. BIO TECH. 1995;13:486–492. [Google Scholar]
- 31.Kapusta J, Modelska A, Pniewski T, et al. Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Adv Exp Med Biol. 2001;495:299–303. doi: 10.1007/978-1-4615-0685-0_41. [DOI] [PubMed] [Google Scholar]
- 32.Moffat AS. Crop engineering goes south. Science. 1999;285:370–371. doi: 10.1126/science.285.5426.370. [DOI] [PubMed] [Google Scholar]
- 33.Clendennen SK, May GD. Differential gene expression in ripening banana fruit. Plant Physiol. 1997;115:463–469. doi: 10.1104/pp.115.2.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Washam C. Biotechnology creating edible vaccines. Ann Intern Med. 1997;127:499–499. doi: 10.7326/0003-4819-127-6-199709150-00030. [DOI] [PubMed] [Google Scholar]
- 35.Kong Q, Richter L, Yang YF, et al. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci U S A. 2001;98:11539–11544. doi: 10.1073/pnas.191617598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.World Health Organization: The World Health Report 1998 executive summary:life in the 21st century: a vision for all. http://www.who.int/whr/2001/archives/1998/ index.htm. Accessed April 12, 2002.
- 37.Black RE, Brown KH, Becker S, et al. Longitudinal studies of infectious disease and physical growth in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. Am J Epidemiol. 1982;115:315–324. doi: 10.1093/oxfordjournals.aje.a113308. [DOI] [PubMed] [Google Scholar]
- 38.Guerrant RL, Kirchhoff LV, Shields DS, et al. Prospective study of diarrheal illness in Northeastern Brazil: patterns of disease, nutritional impact, etiologies, and risk factors. J Infect Dis. 1983;148:986–997. doi: 10.1093/infdis/148.6.986. [DOI] [PubMed] [Google Scholar]
- 39.Koletzki D, Zankl A, Gelderblom H, et al. Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments. J Gen Virol. 1997;70:2049–2053. doi: 10.1099/0022-1317-78-8-2049. [DOI] [PubMed] [Google Scholar]
- 40.Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci U S A. 1992;89:11745–11749. doi: 10.1073/pnas.89.24.11745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Tsarev S, Tsareva T, Emerson S, et al. ELISA for antibody to hepatitis E virus (HEV) based on complete openended reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis. 1993;168:369–378. doi: 10.1093/infdis/168.2.369. [DOI] [PubMed] [Google Scholar]
- 42.Ball JM, Hardy MK, Conner ME, et al. Recombinant Norwalk virus-like particles as an oral vaccine. Arch Virol. 1996;12:243–2491. doi: 10.1007/978-3-7091-6553-9_26. [DOI] [PubMed] [Google Scholar]
- 43.Crawford SE, Labbe M, Cohen J, et al. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol. 1994;68:5945–5952. doi: 10.1128/jvi.68.9.5945-5952.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Thanavala Y, Yang Y-F, Lyons P, et al. Immunogenictiy of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci U S A. 1995;92:3358–3361. doi: 10.1073/pnas.92.8.3358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Mason HS, Haq TA, Clements JD, et al. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT); potatoes expressing a synthetic LT-B gene. Vaccine. 1998;16:1336–1343. doi: 10.1016/S0264-410X(98)80020-0. [DOI] [PubMed] [Google Scholar]
- 46.Tacket CO, Mason HS, Lonsonky G, et al. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med. 1998;4:607–609. doi: 10.1038/nm0598-607. [DOI] [PubMed] [Google Scholar]
- 47.Yu J, Langridge HR. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol. 2001;19:548–552. doi: 10.1038/89297. [DOI] [PubMed] [Google Scholar]
- 48.Frenck RW, Clemens J. Helicobacter in the developing world. Microbes Infect. 2003;5:705–713. doi: 10.1016/S1286-4579(03)00112-6. [DOI] [PubMed] [Google Scholar]
- 49.Svennerholm A-M, Quiding-Jarbrink M. Priming and expression of immune responses in the gastric mucosa. Microbes Infect. 2003;5:731–739. doi: 10.1016/S1286-4579(03)00113-8. [DOI] [PubMed] [Google Scholar]
- 50.Svennerholm A-M. Prospects for a mucosally administered vaccine against Helicobacter pylori. Vaccine. 2003;21:347–353. doi: 10.1016/S0264-410X(02)00614-X. [DOI] [PubMed] [Google Scholar]
- 51.Spencer RC. Bacillus anthracis. J Clin Path. 2003;56:182–186. doi: 10.1136/jcp.56.3.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Aziz MA, Singh S, Kumar PA, et al. Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. Biochem Biophys Res Commun. 2002;299:345–351. doi: 10.1016/S0006-291X(02)02625-6. [DOI] [PubMed] [Google Scholar]
- 53.Sussman H. Spinach makes a safer anthrax vaccine. Drug Discovery Today. 2003;8:428–430. doi: 10.1016/S1359-6446(03)02706-5. [DOI] [PubMed] [Google Scholar]
- 54.Perr HA. Children and genetically engineered food: potentials and problems. J Pediatr Gastroenterol Nutr. 2002;35:475–486. doi: 10.1097/00005176-200210000-00005. [DOI] [PubMed] [Google Scholar]
